Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹152 Cr₹115 Cr₹85 Cr₹71 Cr₹42 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹152 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹152 Cr
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹152 Cr
32.18
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹329.4 Cr 2.4% 22.4% 65.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,052.0 Cr 0.3% -3.7% -4.7% Stock Analytics
DIVIS LABORATORIES ₹169,336.0 Cr 2.4% 6.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,311.0 Cr -0.8% -1.5% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹111,264.0 Cr 7.9% 4.6% 4.6% Stock Analytics
CIPLA ₹105,484.0 Cr 5.5% 5.4% -18.5% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

2.4%

22.4%

65.6%

SENSEX

-0.4%

1.3%

0.8%


You may also like the below Video Courses